Sofie Berg
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
-
- Psoriasis: Treatment and Pathogenesis
- Immunodeficiency and Autoimmune Disorders
Papers in
- Genetics 17
- Inflammatory Bowel Disease 17
-
- Microscopic Colitis 2
- Multiple and Secondary Primary Cancers 1
- Co-authors
- Remo Panaccione (12 shared papers)Anne Martin Robinson (8 shared papers)William J. Sandborn (6 shared papers)Geert D’Haens (8 shared papers)Jen‐Fue Maa (4 shared papers)Joel H. Petersson (7 shared papers)Stefan Schreiber (5 shared papers)Walter Reinisch (7 shared papers)
- Journals
- Gastroenterology (5 papers)Journal of Crohn s and Colitis (3 papers)The Lancet (2 papers)The American Journal of Gastroenterology (2 papers)Inflammatory Bowel Diseases (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Sofie Berg
19 papers receiving 851 citations
Sofie Berg's Hit Papers
Peers
Comparison fields: 5 of 43
- Genetics 702
- Immunology 177
- Epidemiology 233
- Gastroenterology 32
- Hematology 52
Countries citing papers authored by Sofie Berg
This map shows the geographic impact of Sofie Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Berg more than expected).
Fields of papers citing papers by Sofie Berg
This network shows the impact of papers produced by Sofie Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Berg. The network helps show where Sofie Berg may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials Hit paper breakdown → | 2022 | 307 |
| 2 | Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial Hit paper breakdown → | 2022 | 251 |
| 3 | Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease Hit paper breakdown → | 2024 | 107 |
| 4 | 2020 | 37 | |
| 5 | 2021 | 29 | |
| 6 | 2019 | 27 | |
| 7 | 2018 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2024 | 16 | |
| 12 | 2023 | 11 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2017 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2003 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2017 | 0 |
About Sofie Berg
Sofie Berg is a scholar working on Genetics, Epidemiology, Hematology, Immunology and Surgery, having authored 20 papers that have together received 871 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (17 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Microscopic Colitis (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Eosinophilic Esophagitis (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Appendicitis Diagnosis and Management (1 paper). The work is most often cited by research in Genetics (702 citations), Immunology (177 citations), Epidemiology (233 citations), Gastroenterology (32 citations) and Hematology (52 citations). Sofie Berg has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Remo Panaccione, Anne Martin Robinson, William J. Sandborn, Geert D’Haens, Jen‐Fue Maa, Joel H. Petersson, Stefan Schreiber, Walter Reinisch, Jean Fred Colombel and Robert Löfberg. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, The Lancet, The American Journal of Gastroenterology and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.